Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Esperion Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of ESPR: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders1901187−2
Shares126.3M3.12M113.6M−9.61M (−7.8%)
Value$277.9M$6.86M$171.5M−$99.5M (−36.7%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to ESPR in Q1 2025
InstitutionSharesValue% of portfolio
PenderFund Capital Management Ltd.2,000,000$10.8M9.11%
Marshall Wace, LLP3,632,958$5.23M0.01%
Nuveen, LLC3,087,700$4.45M0.00%
Simplex Trading, LLC146,741$211.0K0.01%
Virtus Investment Advisers, Inc.140,800$202.8K0.06%
Congress Wealth Management LLC46,300$73.6K0.00%
Quadrature Capital Ltd50,436$72.6K0.00%
Los Angeles Capital Management LLC48,172$69.4K0.00%
Brevan Howard Capital Management LP32,933$47.4K0.00%
Crawford Investment Counsel Inc20,000$28.8K0.00%
Meridian Wealth Management, LLC20,000$28.8K0.00%
Farringdon Capital, Ltd.13,514$19.5K0.01%
SIH Partners, LLLP11,411$16.4K0.00%
Stonepine Capital Management, LLC10,000$14.4K0.02%
Pandora Wealth, Inc.7,500$10.8K0.01%
Affinity Capital Advisors, LLC10,000$10.2K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)6,082$8.76K0.00%
Anchor Investment Management, LLC3,000$4.32K0.00%
Massmutual Trust Co FSB1,394$2.01K0.00%
The PNC Financial Services Group, Inc.1,297$1.87K0.00%
Coldstream Capital Management Inc550$7920.00%
Clear Street Markets LLC412$5930.00%
Rialto Wealth Management, LLC296$4270.00%
Jones Financial Companies LLLP73$1100.00%
True Wealth Design, LLC22$320.00%
Bessemer Group Inc127$00.00%

Sold out (28)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (1)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC3,119,253$6.86M